Impact of COVID-19 on Pharmacy Education and Practice : Strategies to Boost Advocacy and Unity among Health Care Organizations
Copyright © 2023. Published by Elsevier Inc..
The global COVID-19 pandemic impacted pharmacy education and changed the pharmacists' scope of practice at the federal and state levels. Based on the Amended Public Readiness and Emergency Preparedness Act, pharmacists were authorized to provide essential services, including testing, treatments, and immunizations at various practice settings. Specifically, the United States Food and Drug Administration issued emergency use authorization for several medications, vaccines, and medical devices. The pandemic also affected the regulatory landscape for pharmacists, pharmacy education, access to care, and delivery of pharmacy services in-person and through telehealth. The pandemic's specific impact on pharmacy education heightened awareness of the well-being of the Academy. This commentary will highlight the impact of COVID-19 on both pharmacy education and practice. It will also provide strategies that educators, researchers, and practitioners can take into future research and action to help promote advocacy and unity among pharmacy organizations.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:87 |
---|---|
Enthalten in: |
American journal of pharmaceutical education - 87(2023), 12 vom: 10. Dez., Seite 100091 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kahaleh, Abby A [VerfasserIn] |
---|
Links: |
---|
Themen: |
Advocacy for the pharmacy profession |
---|
Anmerkungen: |
Date Completed 16.12.2023 Date Revised 16.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ajpe.2023.100091 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364447419 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM364447419 | ||
003 | DE-627 | ||
005 | 20231227133209.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ajpe.2023.100091 |2 doi | |
028 | 5 | 2 | |a pubmed24n1230.xml |
035 | |a (DE-627)NLM364447419 | ||
035 | |a (NLM)37953084 | ||
035 | |a (PII)S0002-9459(23)00092-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kahaleh, Abby A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of COVID-19 on Pharmacy Education and Practice |b Strategies to Boost Advocacy and Unity among Health Care Organizations |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.12.2023 | ||
500 | |a Date Revised 16.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023. Published by Elsevier Inc. | ||
520 | |a The global COVID-19 pandemic impacted pharmacy education and changed the pharmacists' scope of practice at the federal and state levels. Based on the Amended Public Readiness and Emergency Preparedness Act, pharmacists were authorized to provide essential services, including testing, treatments, and immunizations at various practice settings. Specifically, the United States Food and Drug Administration issued emergency use authorization for several medications, vaccines, and medical devices. The pandemic also affected the regulatory landscape for pharmacists, pharmacy education, access to care, and delivery of pharmacy services in-person and through telehealth. The pandemic's specific impact on pharmacy education heightened awareness of the well-being of the Academy. This commentary will highlight the impact of COVID-19 on both pharmacy education and practice. It will also provide strategies that educators, researchers, and practitioners can take into future research and action to help promote advocacy and unity among pharmacy organizations | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Advocacy for the pharmacy profession | |
650 | 4 | |a Expanding the scope of pharmacy practice | |
650 | 4 | |a Scope of pharmacy practice | |
700 | 1 | |a Ellington, Thomas M |e verfasserin |4 aut | |
700 | 1 | |a Coker, Adeola O |e verfasserin |4 aut | |
700 | 1 | |a Tillery, Erika |e verfasserin |4 aut | |
700 | 1 | |a Manasco, Kalen B |e verfasserin |4 aut | |
700 | 1 | |a Truong, Hoai-An |e verfasserin |4 aut | |
700 | 1 | |a Kebodeaux, Clark D |e verfasserin |4 aut | |
700 | 1 | |a Edwards, Krystal L |e verfasserin |4 aut | |
700 | 1 | |a Hayatshahi, Alireza |e verfasserin |4 aut | |
700 | 1 | |a Gumina, Giuseppe |e verfasserin |4 aut | |
700 | 1 | |a Hughes, Jeremy A |e verfasserin |4 aut | |
700 | 1 | |a Fuentes, David G |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t American journal of pharmaceutical education |d 1945 |g 87(2023), 12 vom: 10. Dez., Seite 100091 |w (DE-627)NLM000710369 |x 1553-6467 |7 nnns |
773 | 1 | 8 | |g volume:87 |g year:2023 |g number:12 |g day:10 |g month:12 |g pages:100091 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajpe.2023.100091 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 87 |j 2023 |e 12 |b 10 |c 12 |h 100091 |